GR3003514T3 - - Google Patents

Info

Publication number: GR3003514T3
Authority: GR; Greece
Prior art keywords: antibiotic; preparing; factor; complex; treatment
Prior art date: 1985-12-30

Application number

GR910402184T

Other languages

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-12-30

Filing date

1992-01-03

Publication date

1993-03-16

1992-01-03 Application filed filed Critical

1993-03-16 Publication of GR3003514T3 publication Critical patent/GR3003514T3/el

Links

BEVDFPMXVNOQBI-AXNWEOKVSA-N (19R,22R,34S,37R,40R,52S)-64-[(2S,3R,4R,5S,6S)-3-amino-6-carboxy-4,5-dihydroxyoxan-2-yl]oxy-5,32-dichloro-2,26,31,49-tetrahydroxy-22-(methylamino)-21,35,38,54,56,59-hexaoxo-47-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14(63),15,17(62),23(61),24,26,29(60),30,32,41,43,45(57),46(51),47,49,65-henicosaene-52-carboxylic acid Chemical compound CN[C@@H]1c2ccc(O)c(Oc3cc(O)c(Cl)c(c3)[C@@H]3NC(=O)[C@@H](Cc4ccc(Oc5cc6cc(Oc7ccc(cc7Cl)C(O)C7NC(=O)[C@H](NC(=O)[C@@H]6NC3=O)c3cccc(c3)-c3c(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)cc(O)cc3[C@H](NC7=O)C(O)=O)c5O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3N)C(O)=O)cc4)NC1=O)c2 BEVDFPMXVNOQBI-AXNWEOKVSA-N 0.000 abstract 2
208000035473 Communicable disease Diseases 0.000 abstract 1
230000003115 biocidal effect Effects 0.000 abstract 1
125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
244000005700 microbiome Species 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
- C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/19—Antibiotic
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Peptides Or Proteins (AREA)
Compounds Of Unknown Constitution (AREA)
Medicinal Preparation (AREA)

GR910402184T 1985-12-30 1992-01-03 GR3003514T3 (2)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB858531846A GB8531846D0 (en)	1985-12-30	1985-12-30	Antibiotic a 40926 mannosyl aglycon

Publications (1)

Publication Number	Publication Date
GR3003514T3 true GR3003514T3 (2)	1993-03-16

Family

ID=10590309

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR910402184T GR3003514T3 (2)	1985-12-30	1992-01-03

Country Status (14)

Country	Link
US (1)	US4782042A (2)
EP (1)	EP0228015B1 (2)
JP (1)	JP2514942B2 (2)
KR (2)	KR950010460B1 (2)
AT (1)	ATE71113T1 (2)
DE (1)	DE3683266D1 (2)
DK (1)	DK167815B1 (2)
ES (1)	ES2038593T3 (2)
GB (1)	GB8531846D0 (2)
GR (1)	GR3003514T3 (2)
HU (1)	HU201099B (2)
IE (1)	IE59603B1 (2)
IL (1)	IL81105A (2)
ZA (1)	ZA869716B (2)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK363587A (da) *	1986-07-30	1988-01-31	Smithkline Beckman Corp	Antibiotika og fremstilling heraf under anvendelseaf actinomadura parvosata
GB8621912D0 (en) *	1986-09-11	1986-10-15	Lepetit Spa	Increasing ratio of components of anti-biotic complex
GR871488B (en) *	1986-10-10	1987-11-12	Lepetit Spa	New antibiotics
EP0376042B1 (en) *	1988-12-27	1996-03-13	GRUPPO LEPETIT S.p.A.	Improved chemical process for preparing antibiotic L 17392 (deglucoteicoplanin) and its salts
US5206834A (en) *	1989-10-14	1993-04-27	Mitsubishi Denki Kabushiki Kaisha	Semiconductor memory device performing last in-first out operation and the method for controlling the same
ATE112291T1 (de) *	1989-10-16	1994-10-15	Lilly Co Eli	Glycopeptid-antibiotika.
US5224972A (en) *	1990-09-11	1993-07-06	Frye Gregory C	Coatings with controlled porosity and chemical properties
WO1992010516A1 (en) *	1990-12-05	1992-06-25	Gruppo Lepetit S.P.A.	38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them
EP0505735A1 (en)	1991-03-27	1992-09-30	GRUPPO LEPETIT S.p.A.	Antibiotic A 40926 ester derivatives
US5606036A (en) *	1991-03-27	1997-02-25	Gruppo Lepetit Spa	Antibiotic A 40926 ester derivatives
US5750509A (en) *	1991-07-29	1998-05-12	Gruppo Lepetit S.P.A.	Amide derivatives of antibiotic A 40926
CN1036654C (zh) *	1993-01-01	1997-12-10	格鲁波莱佩蒂特公司	抗菌素a40926的酰氨衍生物及其制备方法
DE69633234T2 (de) *	1995-07-05	2005-09-15	Aventis Bulk S.P.A.	Reinigung von dalbeheptide-antibiotika mittels isoelektrofokussierung
KR20000010589A (ko)	1996-04-23	2000-02-15	클라우디오 쿼르타	항생제a40926의아미드유도체의개선된화학적제조방법
AU2003294262B2 (en) *	2002-11-18	2007-08-23	Vicuron Pharmaceuticals Inc.	Methods of administering dalbavancin for treatment of bacterial infections
US7119061B2 (en) *	2002-11-18	2006-10-10	Vicuron Pharmaceuticals, Inc.	Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en)	2002-11-18	2006-04-06	Vicuron Pharmaceuticals Inc.	Dalbavancin compositions for treatment of bacterial infections
JP5852880B2 (ja) *	2011-12-28	2016-02-03	国立研究開発法人国立循環器病研究センター	温度感応性材料
WO2020222100A1 (en) *	2019-04-30	2020-11-05	Actygea S.R.L.	Method for the purification of lipoglycopeptide antibiotics
KR102467772B1 (ko)	2022-08-23	2022-11-16	최세근	디자인에 따라 결합 가능한 모듈이 구비된 신발

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4521335A (en) *	1983-07-13	1985-06-04	Smithkline Beckman Corporation	Aglycone and pseudo-aglycones of the AAD 216 antibiotics
GB8425685D0 (en) *	1984-10-11	1984-11-14	Lepetit Spa	Antibiotic a 40926 complex

1985
- 1985-12-30 GB GB858531846A patent/GB8531846D0/en active Pending
1986
- 1986-12-15 EP EP86117453A patent/EP0228015B1/en not_active Expired - Lifetime
- 1986-12-15 AT AT86117453T patent/ATE71113T1/de not_active IP Right Cessation
- 1986-12-15 ES ES198686117453T patent/ES2038593T3/es not_active Expired - Lifetime
- 1986-12-15 DE DE8686117453T patent/DE3683266D1/de not_active Expired - Lifetime
- 1986-12-19 DK DK617086A patent/DK167815B1/da not_active IP Right Cessation
- 1986-12-23 US US06/945,732 patent/US4782042A/en not_active Expired - Fee Related
- 1986-12-23 IE IE338186A patent/IE59603B1/en not_active IP Right Cessation
- 1986-12-26 IL IL81105A patent/IL81105A/xx not_active IP Right Cessation
- 1986-12-29 JP JP61315964A patent/JP2514942B2/ja not_active Expired - Lifetime
- 1986-12-29 KR KR1019860011487A patent/KR950010460B1/ko not_active Expired - Fee Related
- 1986-12-29 ZA ZA869716A patent/ZA869716B/xx unknown
- 1986-12-29 HU HU865503A patent/HU201099B/hu not_active IP Right Cessation
1987
- 1987-07-01 KR KR1019870006803A patent/KR960010556B1/ko not_active Expired - Fee Related
1992
- 1992-01-03 GR GR910402184T patent/GR3003514T3/el unknown

Also Published As

Publication number	Publication date
GB8531846D0 (en)	1986-02-05
JP2514942B2 (ja)	1996-07-10
HU201099B (en)	1990-09-28
ZA869716B (en)	1987-10-28
JPS62175499A (ja)	1987-08-01
US4782042A (en)	1988-11-01
IL81105A0 (en)	1987-03-31
IE59603B1 (en)	1994-03-09
DK617086D0 (da)	1986-12-19
DK617086A (da)	1987-07-01
IL81105A (en)	1991-09-16
ATE71113T1 (de)	1992-01-15
DK167815B1 (da)	1993-12-20
IE863381L (en)	1987-06-30
KR870006193A (ko)	1987-07-09
KR960010556B1 (ko)	1996-08-02
EP0228015A2 (en)	1987-07-08
KR950010460B1 (ko)	1995-09-18
EP0228015B1 (en)	1992-01-02
DE3683266D1 (de)	1992-02-13
KR890002230A (ko)	1989-04-08
EP0228015A3 (en)	1987-12-16
HUT43091A (en)	1987-09-28
ES2038593T3 (es)	1993-08-01

Publication	Publication Date	Title
ZA869716B (en)	1987-10-28	Antibiotic a 40926 mannosyl aglycon
MY101178A (en)	1991-07-31	Antibiotic a 40926 n-acylaminoglucuronyl aglycons and antibiotic a 40926 aglycon
ES8800160A1 (es)	1987-10-16	Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
PT85885A (en)	1987-11-01	Process for preparing novel de-acyl a 40926 antibiotics
IL83194A0 (en)	1987-12-31	Beta-lactam compound,method for preparing the same,medicinal composition containing the same for infectious bacterial disease therapy and intermediates for synthesis of the same
GR3015052T3 (en)	1995-05-31	Antibiotic GE 2270 factors A1, A2, A3 and H.
GR3015899T3 (en)	1995-07-31	Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2,E and T.
ES8707734A1 (es)	1987-08-16	Procedimiento para la obtencion de cefalosporinas
HU912517D0 (en)	1992-01-28	New 1-diphenyl-methyl-piperazine derivatives, process for their production, and for the production of medical preparations containing thereof
HU9200385D0 (en)	1992-06-29	Megacariocitopoietic factor
GB2087888B (en)	1985-02-27	New bicyclo(2.2.1)heptane derivatives and their use as plant growth regulants
IL74436A0 (en)	1985-05-31	New triazolylalkyl derivatives,a process for their preparation and their use as plant treatment agents
AU6725387A (en)	1988-06-16	Drugs for the treatment and cure of all infectious diseases caused by pathogenic virulent micro-organisms